Total Funding
28
20
Total FundingPost-IPO Debt raised
Growth Score
-5 pts
Heat Score
-45 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
347886
MEDRx is a pharmaceutical drug development company that is engaged in the research and development of new medicines for patient.
Hayford Nkansah Brako: CEO & Founder
About the Company
MedRx is a pharmaceutical company that develops pharmaceutical drugs based on the transdermal absorption system in Japan. It develops medicines based on Ionic Liquid Transdermal System. The company’s products in the pipeline include MRX-4TZT; MRX-5LBT; MRX-10XT; and MRX-5DML. It also offers microneedle patch for delivery of vaccines and/or
APIs through the skin. MedRx Co., Ltd. was founded in 2002 and is headquartered in Higashikagawa, Japan.
